← Back to Discover
EQT Fund Management S.a r.l.
Period ended Sep 30, 2026 · Latest filing Nov 12, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $947,443,764
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- WAYSTAR HLDG CORP · COM · 946784105 · shares: $630,444,934
- PHARVARIS N V · COM · N69605108 · shares: $108,628,597
- OCULIS HOLDING AG · ORDINARY SHARES · H5870P102 · shares: $64,915,746
- AGOMAB THERAPEUTICS NV · SPONSORED ADS · 00860C102 · shares: $57,076,111
- EVOMMUNE INC · COM SHS · 30054Y107 · shares: $43,681,465
- ELECTRA THERAPEUTICS INC · COM · 284825106 · shares: $42,696,911
Reported holdings
6 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| WAYSTAR HLDG CORP | COM | 946784105 | — | 24,879,437 shares | $630,444,934 |
| PHARVARIS N V | COM | N69605108 | — | 3,424,609 shares | $108,628,597 |
| OCULIS HOLDING AG | ORDINARY SHARES | H5870P102 | — | 6,950,294 shares | $64,915,746 |
| AGOMAB THERAPEUTICS NV | SPONSORED ADS | 00860C102 | — | 5,141,992 shares | $57,076,111 |
| EVOMMUNE INC | COM SHS | 30054Y107 | — | 5,288,313 shares | $43,681,465 |
| ELECTRA THERAPEUTICS INC | COM | 284825106 | — | 3,795,281 shares | $42,696,911 |